Investigating Ago2 mRNA expression and DFS, we find evidence of a difference in DFS comparing Ago2 expression Low and High, when considering all breast cancers (p = 0.0012, n = 1764) (Fig. 5a). The gene discussed is AGO2; the disease is breast carcinoma.